Washington Growth Strategies LLC Acquires 11,435 Shares of SPDR S&P Biotech ETF $XBI

Washington Growth Strategies LLC increased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 14,117.3% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 11,516 shares of the exchange traded fund’s stock after purchasing an additional 11,435 shares during the quarter. SPDR S&P Biotech ETF makes up about 0.7% of Washington Growth Strategies LLC’s investment portfolio, making the stock its 24th largest holding. Washington Growth Strategies LLC’s holdings in SPDR S&P Biotech ETF were worth $955,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in XBI. GAMMA Investing LLC lifted its stake in shares of SPDR S&P Biotech ETF by 6,251.2% in the 1st quarter. GAMMA Investing LLC now owns 21,086 shares of the exchange traded fund’s stock valued at $1,710,000 after purchasing an additional 20,754 shares during the period. NBC Securities Inc. lifted its stake in shares of SPDR S&P Biotech ETF by 118,075.0% in the 1st quarter. NBC Securities Inc. now owns 4,727 shares of the exchange traded fund’s stock valued at $383,000 after purchasing an additional 4,723 shares during the period. Hennion & Walsh Asset Management Inc. lifted its stake in shares of SPDR S&P Biotech ETF by 168.4% in the 1st quarter. Hennion & Walsh Asset Management Inc. now owns 11,781 shares of the exchange traded fund’s stock valued at $955,000 after purchasing an additional 7,391 shares during the period. Lmcg Investments LLC purchased a new position in shares of SPDR S&P Biotech ETF in the 1st quarter valued at approximately $2,175,000. Finally, Edge Wealth Management LLC lifted its stake in shares of SPDR S&P Biotech ETF by 2.6% in the 1st quarter. Edge Wealth Management LLC now owns 110,468 shares of the exchange traded fund’s stock valued at $8,959,000 after purchasing an additional 2,791 shares during the period.

SPDR S&P Biotech ETF Stock Up 1.0%

XBI opened at $103.60 on Friday. The stock has a market cap of $5.91 billion, a PE ratio of 11.47 and a beta of 0.97. The business has a 50 day moving average of $92.10 and a 200-day moving average of $85.17. SPDR S&P Biotech ETF has a 52 week low of $66.66 and a 52 week high of $105.47.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.